No Data
The first batch of pharmaceutical fund's third quarter report is released! Shareholding in US stocks reduced, while increasing holdings in Hong Kong stocks and A-shares.
The first batch of fund managers exposed in the third quarter medical investment strategy, significantly increased the proportion of innovative drugs, especially the position of Hong Kong-listed innovative drugs with greater flexibility.
Express News | China Securities Co.,Ltd.: Focus on investment opportunities in seven directions in the health care industry.
MODERN CHI MED: 2024 INTERIM REPORT
Morgan Stanley Fund: Will the pharmaceutical stocks "counterattack" as the Federal Reserve cuts interest rates?
Morgan Stanley Fund said that if the Federal Reserve cuts interest rates, risk appetite for funds may increase, and innovative drugs with higher growth potential may receive more risk capital favor in the short to medium term, gaining some upward momentum.
Modern Chinese Medicine Group Swings to Loss in H1
Modern Traditional Chinese Medicine Group (01643) released its interim performance results, with a net loss of 6.852 million yuan, a year-on-year change from profit to loss.
Modern Traditional Chinese Medicine Group (01643) releases its interim performance for the 6-month period ending June 30, 2024, with the group achieving...
No Data
No Data